EMEA-000309-PIP02-14
Key facts
| Invented name |
RoActemra
|
| Active substance |
tocilizumab
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0135/2015
|
| PIP number |
EMEA-000309-PIP02-14
|
| Pharmaceutical form(s) |
Solution for injection (in pre-filled syringe)
|
| Condition(s) / indication(s) |
Treatment of vasculitides
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Roche Registration Limited
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions/indications
|